Public Release: 

Nanoscience and the future of healthcare kick off first day of ACS national meeting in Boston

American Chemical Society

WASHINGTON, Aug. 2, 2018 -- The profound impact of nanoscience and chemistry on the future of healthcare will be explored in the opening session of the American Chemical Society's (ACS') 256th National Meeting & Exposition, Aug. 19-23 in Boston. ACS President Peter K. Dorhout, Ph.D., is cosponsoring the session, which will set the stage for the meeting's theme of "Nanoscience, Nanotechnology & Beyond."

Opening session: "21st Century Medicine Will Transform Healthcare: Opportunities for Nanoscience and Chemistry" by Leroy Hood, Ph.D., of the Institute for Systems Biology in Seattle. Paul Weiss, Ph.D., of UCLA will moderate the session, which will take place Sunday, Aug. 19, 4-5 p.m. in the Boston Convention & Exposition Center, Ballroom West.

Welcome reception: The reception will take place at the Expo & Career Fair, Sunday, Aug. 19, 5:30-7:30 p.m., in the Boston Convention & Exposition Center, Hall A.

Presidential programming and events will emphasize Dorhout's themes of enhancing chemists' adaptability and promoting safety and diversity, beginning with the two-part symposium "Moving the Safety Values of the ACS Forward," which highlights safety education, communication and leadership.

Presidential symposia:

  • Moving the Safety Values of the ACS Forward, Sunday, Aug. 19, 8:30 a.m.-3:30 p.m., Boston Convention & Exposition Center, Room 103
  • Ion Transport at the Nanoscale: Research and Capabilities at the DOE's Nano Centers, Monday, Aug. 20, 8 a.m.-4:35 p.m., Boston Convention & Exposition Center, Room 103
  • Growing with Project SEED: 50 Years and 10,000+ Students, Monday, Aug. 20, 8:30-11:30 a.m., Sheraton Boston Hotel, Back Bay D
  • Synthetic Biology: The State of the Science, Monday, Aug. 20, 8:30 a.m.-5:00 p.m., Boston Convention & Exposition Center, Room 257 B

Presidential events:

  • Presidential outreach event at the Boston Children's Museum, Saturday, Aug. 18, 11 a.m.-2 p.m. Everyone is invited to explore the world of chemistry with hands-on activities at this fun, free ACS Kids Zone event.
  • Graduate and Postdoctoral Scholars Lecture and Reception, featuring cartoonist Jorge Cham, Monday, Aug. 20, 7-8:30 p.m., Boston Convention & Exposition Center, Ballroom West

Cosponsored by the ACS president:

  • Chemistry as a Second Language: Strategies for Global Scientific Communication
  • Importance of LGBTQ+ Role Models and Mentors in Chemical Sciences: A Symposium in Honor of Barbara Belmont
  • Artificial Intelligence and its Impact on the Chemical Enterprise
  • Advances in Human Space Exploration: Second ACS NASA Symposium
  • Celebrating the Success of an Exchange Program for German and American Chemistry Students
  • Role of the Chemical Sciences in Brain Research and the BRAIN Initiative
  • LGBTQ+ Presidential Reception

###

For more research news, journalists and public information officers are encouraged to apply for complimentary press registration for the American Chemical Society's 256th National Meeting & Exposition, Aug. 19-23 in Boston.

The American Chemical Society, the world's largest scientific society, is a not-for-profit organization chartered by the U.S. Congress. ACS is a global leader in providing access to chemistry-related information and research through its multiple databases, peer-reviewed journals and scientific conferences. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive press releases from the American Chemical Society, contact newsroom@acs.org.

Follow us on Twitter | Facebook

Hood:

Title

21st Century Medicine Will Transform Healthcare: Opportunities for Nanoscience and Chemistry

Abstract

Systems medicine, the application of systems approaches to disease, places medicine at a fascinating tipping point--promising a revolution in the practice of healthcare. I will discuss how systems biology approaches have framed systems medicine, and I will discuss some of the new systems-driven technologies and strategies that have catalyzed this tipping point. There are special opportunities for nanosciences and chemistry in the generation of systems-driven tools for the analyses of single molecules, single cells and the assessment of the complexities of deciphering human complexity. Moreover, four converging thrusts--systems medicine (various technologies), big data (and its analytics), the digitalization of personal measurements and patient-activated social networks--are leading to a proactive healthcare that is predictive, personalized, preventive and participatory (P4). I will contrast P4 healthcare, embodying 21st century medicine, with contemporary medicine and discuss its societal implications for healthcare. P4 healthcare has two central thrusts--wellness and disease. I will discuss our successful effort to introduce P4 healthcare into the current healthcare system with a P4 pilot program on scientific (quantitative) wellness--a longitudinal, high-dimensional data cloud (personal, dense, dynamic data clouds) study on each of 108 well patients over 2014.

In 2015, we started the company Arivale to bring scientific wellness to consumers, and it now has more than 4000 clients. I will discuss the new insights emerging from computational studies of all of these personal data clouds.

In 2016, my institute, the Institute for Systems Biology (ISB), affiliated with Providence St. Joseph Health to become its research arm, and I became its Chief Science Officer. This enables us to bring 21st century medicine to the US healthcare system in the form of a series of clinical trials for scientific wellness, Alzheimer's disease and many other diseases employing personal, dense, dynamic data clouds. These data will provide new approaches to the elucidation of wellness and disease mechanism as well as the identification of relevant biomarkers and even novel drug target candidates. The nanosciences will play a critical role in miniaturizing the genomics and omic human assays, increasing their throughput and reducing their costs.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.